Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Magnetically responsive microbubbles (MagMBs), consisting of an oxygen gas core and a phospholipid coating functionalised with Rose Bengal (RB) and/or 5-fluorouracil (5-FU), were assessed as a delivery vehicle for the targeted treatment of pancreatic cancer using combined antimetabolite and sonodynamic therapy (SDT). MagMBs delivering the combined 5-FU/SDT treatment produced a reduction in cell viability of over 50% when tested against a panel of four pancreatic cancer cell lines in vitro. Intravenous administration of the MagMBs to mice bearing orthotopic human xenograft BxPC-3 tumours yielded a 48.3% reduction in tumour volume relative to an untreated control group (p<0.05) when the tumour was exposed to both external magnetic and ultrasound fields during administration of the MagMBs. In contrast, application of an external ultrasound field alone resulted in a 27% reduction in tumour volume. In addition, activated caspase and BAX protein levels were both observed to be significantly elevated in tumours harvested from animals treated with the MagMBs in the presence of magnetic and ultrasonic fields when compared to expression of those proteins in tumours from either the control or ultrasound field only groups (p<0.05). These results suggest MagMBs have considerable potential as a platform to enable the targeted delivery of combined sonodynamic/antimetabolite therapy in pancreatic cancer.

Original publication

DOI

10.1016/j.jconrel.2017.07.040

Type

Journal article

Journal

J control release

Publication Date

28/09/2017

Volume

262

Pages

192 - 200

Keywords

5-Fluoruracil, Antimetabolite therapy, Drug delivery, Hypoxia, Magnetic targeting, Microbubbles, Pancreatic cancer, Rose Bengal, Sonodynamic therapy, Animals, Antimetabolites, Antineoplastic, Avidin, Cell Line, Tumor, Cell Survival, Ferric Compounds, Fluorouracil, Humans, Magnetic Phenomena, Metal Nanoparticles, Mice, SCID, Microbubbles, Pancreatic Neoplasms, Rose Bengal, Sonication, Tumor Burden